Lipocine to present at the ladenburg thalmann healthcare conference

Salt lake city, july 6, 2021 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the company will present at the ladenburg thalmann healthcare conference. the conference will be held virtually.

LPCN Ratings Summary

LPCN Quant Ranking